Our Pricing

Wegovy vs Mounjaro UK: Complete Comparison Guide

Published on: June 03, 2026

Choosing between wegovy vs mounjaro uk comparison options requires understanding the clinical differences between these two leading weight loss injections. Both are licensed by the MHRA for weight management in the UK, but they work through distinct mechanisms and produce different results in clinical trials. At Cured Pharmacy, our UK-registered clinical team helps patients navigate this decision with transparent pricing and expert guidance.

How Mounjaro and Wegovy Work Differently

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed in the UK, whilst Wegovy contains semaglutide, a GLP-1 receptor agonist [1]. This fundamental difference in mechanism explains why clinical trial results vary between the two medications.

GLP-1 receptor agonists like semaglutide work by mimicking a single gut hormone that regulates appetite and blood sugar. Tirzepatide activates both GLP-1 and GIP receptors simultaneously, producing enhanced metabolic effects [1]. In practical terms, this dual action may lead to greater weight reduction in some patients, though individual responses vary significantly.

Both medications slow gastric emptying, reduce appetite, and improve insulin sensitivity. They're administered as once-weekly subcutaneous injections using pre-filled pens. Your UK prescriber will determine which mechanism better suits your medical history and weight management goals during your clinical assessment.

Clinical Trial Results: Wegovy vs Mounjaro UK Efficacy

The SURMOUNT-1 trial demonstrated that patients taking the highest Mounjaro dose (15mg) achieved an average 22.5% body weight reduction over 72 weeks [1]. In comparison, the STEP-1 trial showed Wegovy users lost an average of 14.9% of their body weight over 68 weeks [2].

These figures represent averages from controlled clinical trials. Individual results depend on numerous factors including baseline weight, adherence to treatment, lifestyle modifications, and metabolic response. Some patients respond better to semaglutide's single-pathway approach, whilst others benefit more from tirzepatide's dual mechanism [1][2].

Both medications require gradual dose escalation to minimise gastrointestinal side effects. Mounjaro typically starts at 2.5mg weekly, increasing to a maintenance dose between 5mg and 15mg. Wegovy begins at 0.25mg, escalating to a maintenance dose of 2.4mg weekly [3]. Your prescriber will tailor the escalation schedule to your tolerance and clinical response.

Time to Results

Most patients notice appetite reduction within the first week of either treatment, though measurable weight loss typically becomes apparent after 4-8 weeks [1][2]. Maximum effects generally occur after 6-12 months of continuous treatment at maintenance doses. Clinical trials measured outcomes over 68-72 weeks, demonstrating sustained weight reduction when combined with lifestyle interventions [1][2].

Side Effects: Comparing Mounjaro and Wegovy

Both medications share similar side effect profiles because they affect GLP-1 receptors. The most common adverse effects include nausea, diarrhoea, vomiting, constipation, and abdominal discomfort [3][4]. These gastrointestinal symptoms typically diminish after the first 4-8 weeks as your body adjusts to treatment.

In the SURMOUNT-1 trial, 81% of Mounjaro users experienced at least one gastrointestinal side effect, compared to 80% of Wegovy users in STEP-1 [1][2]. The frequency is comparable, though some patients report different tolerability between the two medications. Dose escalation protocols are specifically designed to minimise these effects.

Serious but rare side effects include pancreatitis, gallbladder disease, and thyroid C-cell tumours (observed in rodent studies but not confirmed in humans) [3][4]. Both medications carry a boxed warning regarding thyroid tumours and are contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Your UK prescriber will screen for these contraindications during your assessment.

Managing Side Effects

Eating smaller, more frequent meals and avoiding high-fat foods can reduce nausea and gastrointestinal discomfort. Staying well-hydrated helps prevent constipation. If side effects persist beyond 8 weeks or become severe, contact your prescriber to discuss dose adjustment or alternative treatments. Never increase your dose faster than prescribed, as this significantly increases side effect risk.

Wegovy vs Mounjaro UK: Cost and Availability

At Cured Pharmacy, Mounjaro starts from £124.99 for genuine UK-licensed pens, whilst other weight loss treatments are available at competitive UK pricing [5]. Final costs depend on your prescribed dose and treatment duration, which your UK prescriber determines during your free online consultation.

Both medications require ongoing treatment to maintain weight loss. Clinical trials show that discontinuing either medication typically results in weight regain [1][2]. Most patients require 12-24 months of continuous treatment to achieve and stabilise their weight management goals, though individual timelines vary considerably.

Cured Pharmacy offers transparent upfront pricing before you complete your clinical assessment. There are no hidden consultation fees, and all prices include UK prescriber review, genuine MHRA-licensed medication, and discreet delivery. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) ensures every prescription meets UK regulatory standards.

Who Can Use Mounjaro or Wegovy in the UK

NICE guidelines recommend GLP-1 receptor agonists for weight management in adults with a BMI of 30 kg/m² or above, or 27 kg/m² with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [6]. Your UK prescriber will calculate your BMI and assess your medical history during consultation.

Both medications are contraindicated in pregnancy, breastfeeding, and patients under 18 years. They should not be used alongside other GLP-1 receptor agonists or if you have a personal or family history of medullary thyroid carcinoma [3][4]. Patients with severe gastrointestinal disease, diabetic retinopathy, or history of pancreatitis require careful evaluation before treatment.

Your online assessment at Cured Pharmacy takes under 3 minutes and covers your medical history, current medications, and weight management goals. A UK-registered prescriber reviews every application individually. If either Mounjaro or Wegovy is unsuitable, alternative treatments like Saxenda or Orlistat may be recommended based on your clinical profile.

Combination with Other Treatments

Neither Mounjaro nor Wegovy should be combined with other GLP-1 receptor agonists or weight loss medications without explicit prescriber approval. They can generally be used alongside most common medications for blood pressure, cholesterol, and other chronic conditions, though dose adjustments may be necessary. Always disclose all current medications during your clinical assessment to avoid potential interactions [3][4].

Making Your Choice: Wegovy vs Mounjaro UK

Clinical trial data suggests Mounjaro may produce greater average weight loss due to its dual receptor mechanism, but individual response varies significantly [1][2]. Some patients achieve excellent results with Wegovy's single-pathway approach, particularly if they've previously responded well to other GLP-1 treatments.

Practical considerations include injection frequency (both are once-weekly), pen design preferences, and individual tolerability. Both medications require similar lifestyle modifications including reduced calorie intake and increased physical activity for optimal results [6]. Your prescriber may recommend starting with one medication and switching if response is inadequate after 12-16 weeks.

At Cured Pharmacy, our UK clinical team provides personalised recommendations based on your medical history, previous treatment responses, and individual circumstances. Start your free online consultation to discuss whether Mounjaro or Wegovy better suits your weight management journey. All treatments are dispensed by our GPhC-registered pharmacy (9012511) with discreet packaging and reliable UK delivery.

Scientific References

1. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. MHRA. https://products.mhra.gov.uk/ [accessed 13 August 2026]
4. Medicines and Healthcare products Regulatory Agency. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. MHRA. https://products.mhra.gov.uk/ [accessed 13 August 2026]
5. Cured Pharmacy. (2025). Weight Loss Treatment Pricing. Cured Pharmacy. https://curedpharmacy.com/collections/weight-loss [accessed 13 August 2026]
6. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary. Weight loss medications work best when combined with a reduced-calorie diet and increased physical activity.